Law360, New York (January 22, 2014, 1:53 PM EST) -- DNA testing company 23andMe Inc. was hit last week with a proposed class action in California federal court accusing it of falsely claiming its saliva collection kit can detect genetic-related health problems, a month after the U.S. Food and Drug Administration ordered the company to halt sales of the test.
The lawsuit, filed Jan. 15, alleges that 23andMe's claims that its DNA collection kits can provide customers with accurate information about their genetic predisposition to a range of health factors are misleading, saying its claims are not based on any scientific testing or clinical data, the suit says.
On Dec. 6,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!